FENOPROFEN CALCIUM Drug Patent Profile
✉ Email this page to a colleague
When do Fenoprofen Calcium patents expire, and what generic alternatives are available?
Fenoprofen Calcium is a drug marketed by Am Therap, Halsey, Misemer, Par Pharm, Quantum Pharmics, Rising, Warner Chilcott, Watson Labs, Ani Pharms, Dava Pharms Inc, Ivax Sub Teva Pharms, Strides Pharma, Sun Pharm Industries, Usl Pharma, Watson Labs Teva, and Xspire Pharma. and is included in thirty-two NDAs.
The generic ingredient in FENOPROFEN CALCIUM is fenoprofen calcium. There are nine drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the fenoprofen calcium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Fenoprofen Calcium
A generic version of FENOPROFEN CALCIUM was approved as fenoprofen calcium by XSPIRE PHARMA on August 17th, 1988.
Summary for FENOPROFEN CALCIUM
US Patents: | 0 |
Applicants: | 16 |
NDAs: | 32 |
Finished Product Suppliers / Packagers: | 4 |
Raw Ingredient (Bulk) Api Vendors: | 211 |
Clinical Trials: | 1 |
Patent Applications: | 2,679 |
Formulation / Manufacturing: | see details |
What excipients (inactive ingredients) are in FENOPROFEN CALCIUM? | FENOPROFEN CALCIUM excipients list |
DailyMed Link: | FENOPROFEN CALCIUM at DailyMed |
Recent Clinical Trials for FENOPROFEN CALCIUM
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Federal University of São Paulo | Phase 4 |
Fundação de Amparo à Pesquisa do Estado de São Paulo | Phase 4 |
Pharmacology for FENOPROFEN CALCIUM
Drug Class | Nonsteroidal Anti-inflammatory Drug |
Mechanism of Action | Cyclooxygenase Inhibitors |